Among the numerous signaling factors, the extracellular signal-regulated kinases 1/2 (ERK1/2) pathway has been suggested to promote cardiac hypertrophy (Yan et al., 2021). The gene discussed is MAPK3; the disease is cardiac hypertrophy.